BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
69 hedge funds and large institutions have $226M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
69
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$16.4M | |
| 2 | +$6.34M | |
| 3 | +$4.38M | |
| 4 |
Millennium Management
New York
|
+$2.46M |
| 5 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$2.38M |
Top Sellers
| 1 | -$18M | |
| 2 | -$6.32M | |
| 3 | -$2.48M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$2.33M |
| 5 |
Goldman Sachs
New York
|
-$2.3M |